Issues
June 2007 - Part 2 Prescription Drug Cost Sharing INTRODUCTION
- "Fiscally Responsible, Clinically Sensitive" Cost Sharing: Contain Costs While Preserving Quality
A. Mark Fendrick, MD; and Michael E. Chernew, PhD  Full Text PDF IMPACT OF COST SHARING ON MEDICATION USE
- Effect of Copayments on Drug Use in the Presence of Annual Payment Limits
George Kephart, PhD; Chris Skedgel, MDE; Ingrid Sketris, PharmD; Paul Grootendorst, PhD; and John Hoar, MPA Full Text PDF
- Effect of a Medication Copayment Increase in Veterans With Schizophrenia
John E. Zeber, PhD; Kyle L. Grazier, PhD; Marcia Valenstein, MD; Frederic C. Blow, PhD; and Paula M. Lantz, PhD Full Text PDF Appendix
- Relationship Between Generic and Preferred-brand Prescription Copayment Differentials and Generic Fill Rate
Douglas E. Mager, MA, and Emily R. Cox, PhD Full Text PDF FORMULARY MANAGEMENT
- Consumer Response to Dual Incentives Under Multitiered Prescription Drug Formularies
Boyd H. Gilman, PhD; and John Kautter, PhD Full Text PDF
- Incentive Formularies and Changes in Prescription Drug Spending
Bruce E. Landon, MD, MBA; Meredith B. Rosenthal, PhD; Sharon-Lise T. Normand, PhD; Claire Spettell, PhD; Adam Lessler, BA; Howard R. Underwood, MD, MBA; and Joseph P. Newhouse, PhD Full Text PDF
- Effects of Benefit Design Change Across 5 Disease States
Diana I. Brixner, PhD, RPh; Vijay N. Joish, PhD; Gary M. Oderda, PharmD, MPH; Steven G. Avey, RPh; Douglas M. Hanson, MA; and H. Eric Cannon, PharmD Full Text PDF
- Formulary Tier Placement for Commonly Prescribed Branded Drugs: Benchmarking and Creation of a Preferred Placement Index
C. Daniel Mullins, PhD; Francis B. Palumbo, PhD; and Mojdeh Saba, BS Full Text PDF
|
|
